130 related articles for article (PubMed ID: 6208291)
1. Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia.
Klein RJ; Friedman-Kien AE
J Invest Dermatol; 1984 Nov; 83(5):344-6. PubMed ID: 6208291
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
Coen DM; Fleming HE; Leslie LK; Retondo MJ
J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
[TBL] [Abstract][Full Text] [Related]
3. Effect of discontinuous acyclovir treatment on in vitro reactivation of herpes simplex virus from latently infected trigeminal ganglia.
Klein RJ; Friedman-Kien AE; DeStefano E
Antimicrob Agents Chemother; 1983 Jul; 24(1):129-31. PubMed ID: 6312871
[TBL] [Abstract][Full Text] [Related]
4. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
[TBL] [Abstract][Full Text] [Related]
5. Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus.
Janz C; Wigand R
Arch Virol; 1982; 73(2):135-43. PubMed ID: 6184033
[TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
Klein RJ
Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
Tenser RB; Gaydos A; Hay KA
J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
Bastow KF; Derse DD; Cheng YC
Antimicrob Agents Chemother; 1983 Jun; 23(6):914-7. PubMed ID: 6311091
[TBL] [Abstract][Full Text] [Related]
9. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
Field H; McMillan A; Darby G
J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
[TBL] [Abstract][Full Text] [Related]
10. Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes simplex virus in vitro.
Park NH; Pavan-Langston D; Declercq E
Am J Med; 1982 Jul; 73(1A):151-4. PubMed ID: 6285706
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia.
Leib DA; Ruffner KL; Hildebrand C; Schaffer PA; Wright GE; Coen DM
Antimicrob Agents Chemother; 1990 Jun; 34(6):1285-6. PubMed ID: 2168150
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Pharm Res; 1987 Jun; 4(3):200-6. PubMed ID: 2855541
[TBL] [Abstract][Full Text] [Related]
13. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
Svennerholm B; Vahlne A; Lycke E
Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
[TBL] [Abstract][Full Text] [Related]
14. Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells.
Suzutani T; Machida H; Sakuma T
Antimicrob Agents Chemother; 1988 Jul; 32(7):1046-52. PubMed ID: 2847637
[TBL] [Abstract][Full Text] [Related]
15. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
Liu WG; Chen ZJ; Song JZ; Ma ZX
Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
[TBL] [Abstract][Full Text] [Related]
16. Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal ganglia.
Lewis ME; Warren KG; Jeffrey VM; Tyrrell DL
Antimicrob Agents Chemother; 1983 Mar; 23(3):487-9. PubMed ID: 6303216
[TBL] [Abstract][Full Text] [Related]
17. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
Gephart JF; Lerner AM
Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
[TBL] [Abstract][Full Text] [Related]
19. In vitro system for studying the efficacy of antiviral agents in preventing the reactivation of latent herpes simplex virus.
Wohlenberg C; Openshaw H; Notkins AL
Antimicrob Agents Chemother; 1979 Apr; 15(4):625-7. PubMed ID: 223499
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
Alenius S
Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
